Lawrence A Kenyon Outlook Therapeutics, Inc. (OTLK) insider trading activity

OTLK Quotes by TradingView

Lawrence A Kenyon is Chief Financial Officer of Outlook Therapeutics, Inc.. Currently has a direct ownership of 5,946 shares of OTLK, which is worth approximately $8,443. The most recent transaction as insider was on Sep 26, 2024, when has been sold 5,000 shares (Common Stock) at a price of $5.69 per share, resulting in proceeds of $28,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.95K
68.58% 3M change
68.58% 12M change
Total Value Held $8,443

LAWRENCE A KENYON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 26 2024
BUY
Open market or private purchase
$28,450 $5.69 p/Share
5,000 Added 45.68%
5,946 Common Stock
Apr 20 2021
BUY
Open market or private purchase
$18,300 $1.83 p/Share
10,000 Added 34.57%
18,926 Common Stock
LAK

Lawrence A Kenyon

Chief Financial Officer
Monmouth Junction, NJ

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLK